STEPS: A framework for surveillance
burden in all countries. In developing countries the burden of disease caused by NCD is increasing rapidly and will have significant social, economic, and health consequences. Based on current trends, by the year 2020 noncommunicable diseases are expected to account for 73% of deaths and 60% of the global disease burden.
Download STEPS: A framework for surveillance
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
NCD Burden of Disease - Centers for Disease Control and ...
www.cdc.govNCD Burden of Disease . Prevalence • The number of existing cases divided by the population count • Measured at a point in time rather than over some interval • Typically shown as a percentage • Influenced by incidence and survival. • Like incidence, can be used to describe disease in a population
Burden of Disease in England compared with 22 peer countries
assets.publishing.service.gov.ukInternational comparisons of England with 22 peer countries from the Global Burden of Disease programme 6. Introduction . The Global Burden of Disease (GBD) project, as developed and maintained by the Institute for Health Metrics and Evaluation (IHME), aims to produce the best possible comparable estimates of ill health and injury around the ...
Guidelines for Prevention and Management of Stroke
main.mohfw.gov.inStroke, a major Non-Communicable Disease (NCD), is responsible for 3.5% ofdisabilityadjusted life year (DALY) in India.Apart from risk factors like hypertension, ... 1.1.Magnitude of Stroke burden in India Stroke is the second leading cause of …
Primary Health Care for Noncommunicable Diseases in the ...
pidswebs.pids.gov.phand child health (MCH) conditions still comprise a significant proportion of disease burden, their share has declined in the last three (3) decades while almost all NCDs have been increasing precipitously. For instance, the burden of ischemic heart disease (IHD) in DALYs increased from 1.9% in 1990 to 7.5% in 2019 (Table 1).
Introduction to NCD Epidemiology Presentation
www.cdc.govIntroduction to NCD Epidemiology . Non-Communicable Disease (NCD): Definition (cont.) • Chronic conditions are characterized by the following: – Do not result from an (acute) infectious process – Are “not communicable” – Cause premature morbidity, dysfunction, and reduced quality of life – Usually develop and progress over long ...
Action Plan for the Prevention and Control of ...
www.euro.who.intthe disease burden from NCD by taking integrated action, improving the quality of life and making healthy life expectancy more equitable within and between Member States. Objectives • To take integrated action on risk factors and their underlying determinants across sectors • To strengthen health systems for improved prevention and control ...
Package of Essential Noncommunicable ( PEN ) Disease ...
www.who.inthigh proportion of the NCD burden. Effective approaches to reduce the NCD burden in LMIC include a mixture of population-wide and individual interven-tions. Such cost-effective interventions are already available and include methods for early detection of NCDs and their diagnoses using inexpensive technologies, non pharmaco-